Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Lifeline CoFRA:L8B +10.60%85 5-Year Yield-on-Cost % is 7.09 as of Aug. 01, 2026, which is 75% above its 10-year median of 4.05. GuruFocus rates FRA:L8B with a GF Score™ of 85/100 and a GF Value™ of €8.18. The stock has 3 warning signs investors should review. Among 319 Medical Devices & Instruments companies, Japan Lifeline Co ranks better than 83.39% on this metric.
Japan Lifeline Co's yield on cost for the quarter that ended in Mar. 2026 was 7.09.
The historical rank and industry rank for Japan Lifeline Co's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:L8B'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.57 Med: 4.05 Max: 7.83
Current: 7.09
During the past 13 years, Japan Lifeline Co's highest Yield on Cost was 7.83. The lowest was 0.57. And the median was 4.05.
FRA:L8B's 5-Year Yield-on-Cost % is ranked better than 83.39% of 319
companies
in the Medical Devices & Instruments industry
Industry Median: 2.45
vs FRA:L8B: 7.09
Japan Lifeline Co (FRA:L8B) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Japan Lifeline Co 5-Year Yield-on-Cost % Related Terms
FRA:L8B vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Japan Lifeline Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's 5-Year Yield-on-Cost % falls into.
Japan Lifeline Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Japan Lifeline Co (FRA:L8B) has a 5-Year Yield-on-Cost % of 7.09 as of Aug. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Japan Lifeline Co and its competitors. This is 75% above median its historical median of 4.05. Over the past decade, Japan Lifeline Co's 5-Year Yield-on-Cost % has ranged from 0.57 to 7.83. According to the industry distribution chart, Japan Lifeline Co ranks #53 out of 319 companies in the Medical Devices & Instruments industry, placing it in the top 16.6%.
Is Japan Lifeline Co's 5-Year Yield-on-Cost % too high?
Japan Lifeline Co's current 5-Year Yield-on-Cost % of 7.09 is 75% above median its 10-year median of 4.05. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 7.83. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.45. Japan Lifeline Co's value of 7.09 is 189.4% above this industry median. Based on the distribution chart, Japan Lifeline Co ranks #53 out of 319 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Japan Lifeline Co has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #53 out of 319 companies for 5-Year Yield-on-Cost %. This places Japan Lifeline Co in the top 17% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.45. Japan Lifeline Co's value of 7.09 is 189.4% above this benchmark. Historically, Japan Lifeline Co's own 5-Year Yield-on-Cost % has ranged from 0.57 to 7.83 over the past decade. While the company's 10-year median is 4.05 vs. the industry median of 2.45, Japan Lifeline Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.45, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Lifeline Co's current 5-Year Yield-on-Cost % of 7.09 is 189.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Japan Lifeline Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current 5-Year Yield-on-Cost % is 7.09, which is 75% above median its own 10-year median of 4.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Japan Lifeline Co (FRA:L8B) has a current 5-Year Yield-on-Cost % of 7.09. The stock's GF Value™ is €8.18, compared to a current price of €8.35 — trading 2.1% above its estimated fair value. The current 5-Year Yield-on-Cost % is 7.09, which is 75% above median its 10-year median of 4.05 and 189.4% above the Medical Devices & Instruments industry median of 2.45. Japan Lifeline Co's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Japan Lifeline Co (FRA:L8B), the current 5-Year Yield-on-Cost % is 7.09 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (FRA:L8B) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be overvalued.
The current stock price of €8.35 is trading 2.1% above its estimated GF Value™ of €8.18.
Key valuation signals for FRA:L8B:
5-Year Yield-on-Cost %: 7.09 (75% above median its 10-year median of 4.05)
GF Value™: €8.18 vs. price of €8.35 (2.1% above fair value)
Industry Position: 189.4% above the Medical Devices & Instruments median (#53 of 319)
No single metric tells the full story. See the FRA:L8B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
85GF Score
Get the complete analysis for FRA:L8B
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L8B has been successfully added to your 
